DIAGNOSTIC RETRIEVAL SYSTEMS INC
10-Q, 1997-02-14
SEARCH, DETECTION, NAVAGATION, GUIDANCE, AERONAUTICAL SYS
Previous: LIFECORE BIOMEDICAL INC, SC 13G/A, 1997-02-14
Next: DIAGNOSTIC RETRIEVAL SYSTEMS INC, SC 13G, 1997-02-14





                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                                    FORM 10-Q

(Mark One)

 X     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
       SECURITIES
       EXCHANGE ACT OF 1934
                                               
                                               
 For the quarterly      December 31, 1996 
 period ended
                                               
                               OR
                               
       TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
       SECURITIES
       EXCHANGE ACT OF 1934
                                               
 For the transition              to             
 period from
                                               
                                               
 Commission file  1-8533
 number
                                               
                DIAGNOSTIC/RETRIEVAL SYSTEMS, INC.
      (Exact name of registrant as specified in its charter)
                                               
 Delaware                                            13-2632319
 (State or other                                     (I.R.S.
 jurisdiction of                                     Employer
 incorporation or                                    Identificati
 organization)                                       on No.)
                                               
 5 Sylvan Way, Parsippany,                           07054
 New Jersey
 (Address of principal                               (Zip Code)
 executive offices)
                                               
         201-898-1500                          
 (Registrant's telephone number, including     
 area code)
                                               
 None                                                          
 (Former name, former address and former fiscal year, if changed
 since last report.)

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes _X_     No ___

     As of February 4, 1997, 5,584,093 shares of the registrant's Common Stock,
$.01 par value, were outstanding (exclusive of 420,893 shares held in treasury).


<PAGE>
               DIAGNOSTIC/RETRIEVAL SYSTEMS, INC. AND SUBSIDIARIES
                                        
                                      INDEX

PART 1.        FINANCIAL            
               INFORMATION
               
      Item 1.  Financial Statements           
                                                              
               Condensed Consolidated Balance Sheets -        
               December 31, 1996 and                          3
               March 31, 1996
                                                              
               Condensed Consolidated Statements of Earnings  
               - Three and Nine Months Ended December 31,     4
               1996 and 1995
                                                              
               Condensed Consolidated Statements of Cash      
               Flows - Nine Months Ended December 31, 1996    5
               and 1995
                                                              
               Notes to Condensed Consolidated Financial      6-7
               Statements
                                                              
      Item 2.  Management's Discussion and Analysis of        
               Financial Condition and Results of Operations  8-11
                                                              
PART 2.        OTHER INFORMATION    
               
      Item 1.  Not Applicable                                 
               
      Item 2.  Not Applicable                                 
               
      Item 3.  Not Applicable                                 
               
      Item 4.  Submission of Matters to a Vote of Security    12
               Holders
                                                              
      Item 5.  Not Applicable                                 
               
      Item 6.  Exhibits and Reports on Form 8-K               12
                                                              
SIGNATURES                                                    13

<PAGE>
 DIAGNOSTIC/RETRIEVAL SYSTEMS, INC. AND SUBSIDIARIES
 Condensed Consolidated Balance Sheets
 (Unaudited)

                                           December 31, 1996      March 31, 1996

 Assets

 Current Assets:
  Cash and cash equivalents                 $   8,616,000          $ 22,785,000
  Accounts receivable                          22,224,000            22,942,000
  Inventories, net of progress
        payments                               23,297,000            19,449,000
 Other current assets                           1,918,000             1,464,000
 Total current assets                          56,055,000            66,640,000

 Property, plant and equipment, less accumulated
  depreciation and amortization of $27,480,000
  and $25,744,000 at December 31, 1996 and
  March 31, 1996, respectively                 19,667,000            16,191,000

 Intangible assets, less accumulated amortization of
  $4,555,000 and $4,027,000 at December 31, 1996
  and March 31, 1996, respectively             10,173,000             8,498,000

 Other assets                                   6,180,000             5,922,000

                                             $ 92,075,000          $ 97,251,000

 Liabilities and Stockholders' Equity

 Current liabilities                         $ 23,095,000          $ 32,650,000

 Long-term debt, excluding current
    installments                               32,309,000            32,608,000
 Deferred income taxes                          2,607,000             2,607,000
 Other liabilities                              2,909,000             2,820,000
         Total liabilities                     60,920,000            70,685,000

 Stockholders' equity:

     Common Stock, $.01 par value per share
         Authorized 20,000,000 shares; issued 5,987,986
         shares at December 31, 1996               60,000                     -

     Class A Common Stock, $.01 par value per share
         Authorized 10,000,000 shares; issued 3,739,963
         shares at March 31, 1996                       -                37,000

     Class B Common Stock, $.01 par value per share
         Authorized 20,000,000 shares; issued 2,223,603
         shares at March 31, 1996                       -                22,000

 Additional paid-in capital                    14,159,000            13,639,000
 Retained earnings                             18,944,000            15,022,000
                                               33,163,000            28,720,000
 Treasury Stock, at cost;
     420,893 shares of Common Stock at December 31, 1996;
     432,639 shares of Class A Common Stock and 65,795
     shares of Class B Common Stock at March 31, 1996
                                               (1,619,000)           (1,918,000)

 Unamortized restricted stock
     compensation                                (389,000)             (236,000)
     Net stockholders' equity                  31,155,000            26,566,000

                                             $ 92,075,000          $ 97,251,000

 See accompanying notes to condensed consolidated financial statements.

<PAGE>
 DIAGNOSTIC/RETRIEVAL SYSTEMS, INC. AND SUBSIDIARIES
 Condensed Consolidated Statements of Earnings
 (Unaudited)
<TABLE>
                            <S>
 <S>
                            Three Months Ended December 31, Nine Months Ended December 31,
                                1996              1995             1996            1995
                            <C>                <C>            <C>            <C>
 Revenues                   $ 38,379,000       $ 25,563,000   $ 99,242,000   $65,628,000

 Costs and expenses           35,125,000         23,382,000     90,488,000    60,289,000

  Operating income             3,254,000          2,181,000      8,754,000     5,339,000

 Interest and related expenses  (914,000)          (978,000)    (2,649,000)    1,675,000)

 Other, net                      (36,000)           311,000        324,000       425,000

  Earnings before income taxes 2,304,000          1,514,000      6,429,000     4,089,000

 Income taxes                    898,000            590,000      2,507,000     1,594,000

  Net earnings             $   1,406,000       $    924,000   $  3,922,000   $ 2,495,000


 Earnings per share:
           Primary         $        0.24       $       0.16   $       0.68   $      0.44           
           Fully Diluted   $        0.21       $       0.16   $       0.59   $      0.44

 Weighted average number of shares outstanding:
           Primary             5,774,000          5,677,000      5,733,000      5,647,000
           Fully Diluted       8,970,000          8,303,000      8,918,000      6,552,000

 See accompanying notes to condensed consolidated financial statements.
</TABLE>

<PAGE>
 DIAGNOSTIC/RETRIEVAL SYSTEMS, INC. AND SUBSIDIARIES
 Condensed Consolidated Statements of Cash Flows
 (Unaudited)

                                                  Nine Months Ended December 31,
                                                     1996               1995

 Cash flows from operating activities

     Net earnings                                 $ 3,922,000       $ 2,495,000

 Adjustments to reconcile net earnings to cash
 flows from operating activities:

     Depreciation and amortization                  3,560,000         2,226,000
     Other, net                                       (24,000)          305,000

 Changes in assets and liabilities, net of effects from
 business combinations:

     (Increase) decrease in accounts receivable     1,919,000        (2,859,000)
     (Increase) in inventories                     (3,748,000)       (4,141,000)
     Decrease in other current assets                 283,000           667,000
     (Decrease) in accounts payable and other      (9,664,000)       (2,381,000)
     Other, net                                      (353,000)          194,000

     Net cash used in operating activities         (4,105,000)       (3,494,000)

 Cash flows from investing activities

     Capital expenditures                          (2,461,000)       (3,712,000)
     Sales of fixed assets                            122,000         2,380,000
     Payments pursuant to business combinations,
         net of cash acquired                      (6,226,000)       (4,140,000)

     Net cash used in investing activities         (8,565,000)       (5,472,000)

 Cash flows from financing activities

     Net proceeds from (repayments of)
         short-term debt                             (899,000)           55,000
     Payments on long-term debt                      (651,000)         (374,000)
     Repurchases of convertible subordinated debenture      -        (2,242,000)
     Net proceeds from issuance of senior subordinated
         convertible debentures                             -        23,360,000
     Other, net                                        51,000            39,000

     Net cash provided by (used in) financing
          activities                               (1,499,000)       20,838,000

 Net increase (decrease) in cash and cash
          equivalents                             (14,169,000)       11,872,000
 Cash and cash equivalents, beginning of period    22,785,000        11,197,000

 Cash and cash equivalents, end of period         $ 8,616,000       $23,069,000


 See accompanying notes to condensed consolidated financial statements.

<PAGE>

1)In the opinion of Management, the accompanying unaudited condensed
  consolidated financial statements of Diagnostic/Retrieval Systems, Inc. and
  subsidiaries (the "Company") contain all adjustments (consisting of only
  normal and recurring adjustments) necessary for the fair presentation of the
  Company's consolidated financial position as of December 31, 1996, the
  results of operations for the three and nine months ended December 31, 1996
  and 1995 and cash flows for the nine months ended December 31, 1996 and 1995.
  The  results of operations for the nine months ended December 31, 1996 are not
  necessarily indicative of the results to be expected for the full year.

2)The Company's industrial revenue bonds, due 1998, are supported by an
  irrevocable, direct-pay letter of credit in an amount equal to the principal
  balance plus interest thereon for 45 days.  At December 31, 1996, the
  contingent liability of the Company as guarantor under the letter of credit
  was approximately $1,726,000.  The Company has collateralized the letter of
  credit with accounts receivable and has also agreed to certain financial
  covenants, including the maintenance of: (i) a certain minimum ratio of
  consolidated tangible net worth to total debt (the "Debt Ratio"), (ii)  a
  certain minimum quarterly ratio of earnings before interest and taxes to
  interest, and (iii) a certain minimum balance of billed and unbilled accounts
  receivable.  As a result of the issuance of the Company's 9% Senior
  Subordinated Convertible Debentures, the Debt Ratio at December 31, 1996 was
  below the required minimum ratio.  The Company has obtained a waiver from the
  issuing bank, expiring as of January 2, 1998 (the final redemption date), of
  the required debt ratio and, accordingly, is in compliance with all covenants
  under the letter of credit.

3)Until March 31, 1996, the Company had three authorized classes of stock: a
  class consisting of 10,000,000 shares of Class A Common Stock, a class
  consisting of 20,000,000 shares of Class B Common Stock, and a class
  consisting of 2,000,000 shares of Preferred Stock (none of which has been
  issued).  The holders of the Class A and Class B Common Stock were entitled
  to one vote per share and one-tenth vote per share, respectively.

  On February 7, 1996, the Board of Directors of the Company approved and
  recommended for submission to the stockholders of the Company by a majority
  vote the consideration and approval of an Amended and Restated Certificate of
  Incorporation (the "Restated Certificate"), which amended and restated the
  Company's certificate to (i) effect a reclassification of each share of Class
  A Common Stock and each share of Class B Common Stock into one share of
  Common Stock of the Company, (ii) provide that action by the stockholders may
  be taken only at a duly called annual or special meeting and not by written
  consent and (iii) provide that the stockholders of the Company would have the
  right to make, adopt, alter, amend or repeal the by-laws of the Company only
  upon the affirmative vote of not less than 66 2/3% of the outstanding capital
  stock entitled to vote thereon.  On March 26, 1996, the stockholders approved
  the Restated Certificate.  The Restated Certificate was filed with the
  Secretary of State of the State of Delaware and became effective April 1,
  1996.  Accordingly, the Condensed Consolidated Balance Sheet as of March 31,
  1996 presents Class A and Class B Common Stock; the Condensed Consolidated
  Balance Sheet as of December 31, 1996 presents the new, single class of
  Common Stock.

4)On June 18, 1996, a second-tier subsidiary of Precision Echo, Inc., a
  wholly-owned subsidiary of the Company, acquired substantially all the 
  assets of Vikron, Inc. ("Vikron") for approximately $3.7 million.  
  Vikron, located in St. Croix Falls, Wisconsin, manufactures data and 
  recording heads.

  The acquisition has been accounted for using the purchase method of
  accounting.  Accordingly, Vikron's results of operations from April 1, 1996
  (the effective date of the acquisition) have been included in the Company's
  reported operating results.  The excess of cost over the estimated fair value
  of net assets acquired was approximately $1.6 million and is being amortized
  on a straight-line basis over 15 years.

5)On October 24, 1996, a second-tier subsidiary of Precision Echo, Inc., a
  wholly-owned subsidiary  of the Company, acquired certain assets of Nortronics
  Company, Inc. ("Nortronics"), a Minnesota corporation, for approx-
  imately $2.4 million.  Nortronics manufactures magnetic data recording head
  products.

  The acquisition has been accounted for using the purchase method of
  accounting.  Accordingly, Nortronics' results of operations from July 1,
  1996 (the effective date of the acquisition) have been included in the
  Company's reported operating results.

6)On October 30, 1996, Pacific Technologies, Inc. ("PTI"), a California
  corporation, merged with and into a subsidiary of the Company, for stock
  and cash valued at approximately $0.5 million.  Based in San Diego,
  California, PTI provides systems and software engineering support to the U.S.
  Navy for the testing of shipboard combat systems.

  The merger has been accounted for using the purchase method of accounting.
  Accordingly, PTI's results of operations from July 1, 1996 (the effective date
  of the merger) have been included in the Company's reported operating
  results.


Item  2. Management's Discussion and Analysis of Financial Condition and
         Results of Operations

Results of Operations

  The following table sets forth items in the Condensed Consolidated
  Statements of Earnings as a percent of revenues and presents the percentage
  increase or decrease of those items as compared to the prior period.

<TABLE>
<S>                           <S>                        <S>             <S>                       <S>  
                              Percent of Revenues                        Percent of Revenues
                              Three Months Ended         Percent         Nine Months Ended         Percent
                                  December 31            Changes             December 31           Changes
                              <C>          <C>         <C>               <C>           <C>       <C>
                              1996         1995        1996 vs. 1995     1996          1995      1996 vs. 1995  

Revenues                      100.0        100.0            50.1          100.0        100.0          51.2

Cost and expenses              91.5         91.5            50.2           91.2         91.1          50.1
  
  Operating income              8.5          8.5            49.2            8.8          8.1          64.0

Interest and related expenses  (2.4)        (3.8)           -6.5           (2.7)        (2.5)         58.1

Other, net                     (0.1)         1.2          -111.6            0.3          0.6         -23.8

   Earnings before income taxes 6.0          5.9            52.2            6.4          6.2          57.2

Income taxes                    2.3          2.3            52.2            2.4          2.4          57.3

   Net Earnings                 3.7          3.6            52.2            4.0          3.8          57.2

</TABLE>

  Revenues for the three-month period ended December 31, 1996 increased 50.1%
  to $38.4 million from $25.6 million for the same three-month period in fiscal
  1996.  On a year-to-date basis, revenues increased 51.2% to $99.2 million from
  $65.6 million for the same nine-month period in fiscal 1996. The revenue 
  growth was due primarily to increased shipments associated with the 
  Company's display workstation and electro-optical system product lines, 
  as well as to increases in commercial product sales, which include revenues 
  from businesses acquired within the last year.

  Operating income for the three-month period ended December 31, 1996
  increased 49.2% to $3.3 million from $2.2 million for the same three-
  month period in fiscal 1996.  On a year-to-date basis, operating income  
  increased 64% to $8.8 million from $5.3 million for the same nine-month 
  period in fiscal 1996. Operating income as a percentage of revenue was 8.5% 
  and 8.8% for the three-month and nine-month periods ended December 31, 1996,  
  respectively, as compared with 8.5% and 8.1%, respectively, for  the  
  comparable prior year periods.  The increase in operating income was due 
  primarily to the overall increase in revenues, together with higher profits
  generated by certain of the Company's commercial products.
     
  Interest and related expenses were $0.9 million and $2.6 million for the
  three-month and nine-month periods ended December 31, 1996, as compared to  
  $1.0 million  and $1.7 million in the prior year.  The decrease in the third  
  quarter of fiscal 1997 was due primarily to the redemption of approximately 
  $5.0 million aggregate principal amount of the Company's 8.5% Convertible
  Subordinated Debentures (the "8.5% Debentures") in the fourth quarter of
  fiscal 1996.  These debentures were redeemed using a portion of the proceeds
  from the private placement on September 29, 1995, and November 3, 1995, of 
  $25.0 million aggregate principal amount of 9% Senior Subordinated Convertible
  Debentures due 2003 (the "9% Debentures").  The increase in interest expense 
  for the nine-month period ended December 31, 1996 is due primarily to the  
  overall increase in interest expense associated with the issuance of the 9%
  Debentures, offset in part by reductions in interest resulting from 
  redemptions of approximately $2.3 million and $5.0 million aggregate 
  principal amount of the Company's 8.5% Debentures in the second and
  fourth quarters of fiscal 1996, respectively.  
     
  Other, net was a charge of $36,000 and income of $0.3 million for the three-
  month  and nine-month periods ended December 31, 1996, respectively, as 
  compared to income of $0.3 million and $0.4 million in the comparable periods
  of fiscal 1996.  The decreases were primarily due to an increase in minority
  interest resulting from higher earnings generated by Laurel Technologies,
  a partnership in which the Company has an 80% controlling interest.

  The Company's effective tax rate for the three-month and nine-month periods
  ended December 31, 1996 and 1995 was 39%. The Company records income tax 
  expense based on an estimated effective income tax rate for the full fiscal
  year.  The effective income tax rate and the components of income tax expense
  for the fiscal quarter ended December 31, 1996 have not significantly changed
  from those of the fiscal year ended March 31, 1996.  The provision for income
  taxes includes all estimated income taxes payable to federal and state
  governments, as applicable.

Financial Condition and Liquidity

  Cash and Cash Flow:  Cash and cash equivalents at December 31, 1996 and
  March 31, 1996 represented approximately 9% and 23%, respectively, of total 
  assets.  During the nine-month period ended December 31, 1996, cash decreased
  by approximately $14.2 million.  This decrease resulted from the use of
  approximately $6.2 million in the Vikron and Nortronics acquisitions,
  approximately $2.5 million for capital expenditures and approximately $1.6
  million for debt repayments.  Additionally, approximately $4.1 million was
  used in support of operations, primarily in settlement of accounts payable
  balances associated with material procurement in the fourth quarter of
  fiscal 1996.  This material was purchased in anticipation of production
  activity, primarily for display workstations, scheduled for fiscal 1997.
     
  Capital expenditures, excluding assets acquired as a result of business
  combinations are expected to approximate $3 million for the fiscal year ending
  March 31, 1997.  The majority of these expenditures will be for computer and
  production-related equipment.
     
  Working capital as of December 31, 1996 was $33.0 million, as compared to
  $34.0 million at March 31, 1996. The decrease was primarily due to the uses
  of cash for acquisitions and capital expenditures, partially offset by the
  net effect of lower accounts payable and higher inventory balances.
     
  On May 31, 1996, the Company entered into a revolving line of credit  loan
  agreement with Mellon Bank, N.A. ("Mellon Bank") for a three-year $15
  million unsecured revolving line of credit (the "line of credit"), available
  for working capital and letters of credit. As of December 31, 1996,
  approximately $4.1 million was outstanding against the line of credit. On
  December 6, 1996, the Company entered into a $5 million secured equipment
  line of credit/term loan agreement with Mellon Bank (the "equipment
  facility").  The equipment facility is available for equipment purchases
  made through June 30, 1999.  At December 31, 1996,  there were no outstanding
  borrowings against the equipment facility.
     
  The Company believes that its current working capital position and
  available financing are sufficient to support its current operational needs.
     
  Accounts Receivable and Inventories:  Accounts receivable decreased by
  approximately $1.9 million in the nine-month period ended December 31, 1996,
  net of the effect of assets acquired pursuant to business combinations.   The
  net decrease was due primarily to the collection of an outstanding balance
  associated with one of the Company's display workstation contracts, billed  at
  the end of the second quarter. Generally, there are no contract provisions for
  retainage, and all accounts receivable are expected to be collected within one
  year.

  Inventories increased by approximately $3.7 million from March 31, 1996,
  net of the effect of assets acquired pursuant to business combinations.  The
  increase was due primarily to increased material procurement and production
  activity on certain data recording and commercial products.

<TABLE>
<S>                        <C>              <C>
                           December 31,     March 31, 1996
                               1996
                                           
Quick ratio                    1.3               1.4
Current ratio                  2.4               2.0
Liabilities-to-equity
ratio                          2.0               2.7
Long-term debt,                            
excluding current
installments, to
capitalization                50.9%             55.1%

</TABLE>
                                           
  Backlog:   At December 31, 1996, the Company's backlog of orders was
  approximately $118.6 million as compared to $145.6 million at March 31, 1996.
  The decrease in backlog was due to the net effect of revenues, partially 
  offset by  bookings.  New contract awards of approximately $69 million were
  booked during the nine-month period ended December 31, 1996.

Acquisitions and Related Activities
     
  On June 18, 1996, a second-tier subsidiary of Precision Echo, Inc., a
  wholly-owned subsidiary of the Company, acquired substantially all the assets
  of Vikron, Inc. ("Vikron") for approximately $3.7 million.  Vikron, located in
  St. Croix Falls, Wisconsin, manufactures data and recording heads.

  The acquisition has been accounted for using the purchase method of
  accounting.  Accordingly, Vikron's results of operations from April 1, 1996
  (the effective date of the acquisition) have been included in the Company's
  reported operating results.  The excess of cost over the estimated fair value
  of net assets acquired was approximately $1.6 million and is being amortized 
  on a straight-line basis over 15 years.
     
  On October 24, 1996, a second-tier subsidiary of Precision Echo, Inc.,  a
  wholly-owned subsidiary of the Company, acquired certain assets of Nortronics
  Company, Inc. ("Nortronics"), a Minnesota corporation, for approximately  $2.4
  million.  Nortronics manufactures magnetic data recording head products.

  The acquisition has been accounted for using the purchase method of
  accounting.  Accordingly, Nortronics' results of operations from July 1, 1996
  (the effective date of the acquisition) have been included in the Company's
  reported operating results.

  On October 30, 1996, Pacific Technologies, Inc. ("PTI"), a California
  corporation, merged with and into a subsidiary of the Company, for stock and
  cash valued at approximately $0.5 million.  Based in San Diego, California,  
  PTI provides systems and software engineering support to the  U.S. Navy  for
  the testing of shipboard combat systems.

  The merger has been accounted for using the purchase method of accounting.
  Accordingly, PTI's results of operations from July 1, 1996 (the effective
  date of the merger) have been included in the Company's reported operating 
  results.

Letter of Credit
     
 The Company's industrial revenue bonds, due 1998, are supported by an
 irrevocable, direct-pay letter of credit in an amount equal to the principal
 balance plus interest thereon for 45 days. At December 31, 1996, the contingent
 liability  of the Company as guarantor under the letter of credit was
 approximately $1,726,000.  The Company has collateralized the letter of credit
 with accounts receivable and has also agreed to certain financial covenants,
 including the maintenance of:  (i) a certain minimum ratio of consolidated
 tangible net worth to total debt (the "Debt Ratio"), (ii) a certain minimum
 quarterly ratio of earnings before interest and taxes to interest, and (iii)  a
 certain minimum balance of billed and unbilled accounts receivable. As a result
 of the issuance of the Company's 9% Senior Subordinated Convertible Debentures,
 the Debt Ratio at December 31, 1996 was below the required minimum ratio.   The
 Company has obtained a waiver from the issuing bank, expiring as of January  2,
 1998, (the final redemption date) of the required debt ratio and accordingly is
 in compliance with all covenants under the letter of credit.


     PART II.  OTHER INFORMATION

Item 4.        Submission of Matters to a Vote of Security Holders

          None.

Item 6.        Exhibits and Reports on Form 8-K

          (a)  Exhibits

               11.  Schedule of Computations of Per Share Earnings
               
               27.  Financial Data Schedule

          (b)  Reports on Form 8-K

               None.
<PAGE>
               DIAGNOSTIC/RETRIEVAL SYSTEMS, INC. AND SUBSIDIARIES
                                        
                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934,  the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                              DIAGNOSTIC/RETRIEVAL SYSTEMS, INC.
                                        Registrant


Date: February 14, 1997       /s/ Nancy R. Pitek
                              Nancy R. Pitek
                              Vice President, Finance
                              Treasurer and Secretary



 DIAGNOSTIC/RETRIEVAL SYSTEMS, INC.

 EXHIBIT 11

 SCHEDULE OF COMPUTATIONS OF PER SHARE EARNINGS
<TABLE>
 <S>                      <C>                <C>           <C>               <C>
                        Three Months Ended December 31,   Nine Months Ended  December 31,
                              1996             1995             1996             1995

 PRIMARY

 Net earnings for primary earnings
   per share              $1,406,000          $  924,000    $3,922,000       $2,495,000

 Weighted average number of shares
   outstanding (1)         5,538,000           5,497,000     5,507,000        5,473,000

 Add - common equivalent shares (determined
   using the "treasury stock" method)
   representing shares issuable upon exercise
   of employee stock options 236,000             180,000       226,000          174,000

 Weighted average number of shares used
   in calculation of primary earnings
   per share               5,774,000           5,677,000     5,733,000        5,647,000

 Primary earnings per share $   0.24          $     0.16    $     0.68        $    0.44


 FULLY DILUTED

 Net earnings             $1,406,000          $  924,000    $3,922,000       $2,495,000

 Add - interest on 8.5% Convertible
   Subordinated Debentures, net of applicable
   income taxes (2)           65,000                   -       195,000                -

 Add - interest on 9% Senior Subordinated
   Convertible Debentures, net of applicable
   income taxes              351,000             332,000     1,049,000          332,000

 Add - amortization of deferred issuance costs
   relating to 9% Senior Subordinated Convertible
   Debentures, net of applicable
   income taxes               36,000              31,000       107,000           31,000

 Net earnings for fully diluted earnings
   per share              $1,858,000          $1,287,000    $5,273,000       $2,858,000

 Weighted average number of shares used in
   calculation of primary earnings
   per share               5,774,000           5,677,000     5,733,000        5,647,000

 Add (deduct) incremental shares representing:

 Shares issuable upon exercise of stock options
   included in primary earnings per share
   calculation              (236,000)           (180,000)     (226,000)        (174,000)

 Shares issuable upon exercise of stock options
   based on period-end market
   prices                    274,000             184,000       253,000          185,000

 Shares issuable upon conversion of 8.5%
   Convertible Subordinated
   Debentures (2)            333,000                   -       333,000                -

 Shares issuable upon conversion of 9%
   Senior Subordinated Convertible
   Debentures              2,825,000           2,622,000     2,825,000          894,000

 Weighted average number of shares used
   in calculation of fully diluted
   earnings per share      8,970,000           8,303,000     8,918,000        6,552,000

 Fully diluted earnings
   per share              $     0.21          $     0.16    $     0.59       $     0.44


 (1) Effective April 1, 1996, Class A and Class B Common Stock were reclassified
into a new single class of Common Stock.  See Note 3 to Condensed Consolidated
Financial Statements.

 (2) No adjustment made for all prior year periods, as the effect on reported
per share earnings was antidilutive.

</TABLE>

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
DIAGNOSTIC/RETRIEVAL SYSTEMS, INC. FORM 10-Q FOR THE QUARTERLY PERIOD ENDED
DECEMBER 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-END>                               DEC-31-1996
<CASH>                                       8,616,000
<SECURITIES>                                         0
<RECEIVABLES>                               22,224,000
<ALLOWANCES>                                         0
<INVENTORY>                                 23,297,000
<CURRENT-ASSETS>                            56,055,000
<PP&E>                                      47,147,000
<DEPRECIATION>                              27,480,000
<TOTAL-ASSETS>                              92,075,000
<CURRENT-LIABILITIES>                       23,095,000
<BONDS>                                     32,309,000
                                0
                                          0
<COMMON>                                        60,000
<OTHER-SE>                                  31,095,000
<TOTAL-LIABILITY-AND-EQUITY>                92,075,000
<SALES>                                     38,379,000
<TOTAL-REVENUES>                            38,379,000
<CGS>                                       35,125,000
<TOTAL-COSTS>                               35,125,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             914,000
<INCOME-PRETAX>                              2,304,000
<INCOME-TAX>                                   898,000
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,406,000
<EPS-PRIMARY>                                     0.24
<EPS-DILUTED>                                     0.21
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission